☆ 4.5 Article

Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models

VIROLOGY JOURNAL (2022)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters

Rana Abdelnabi et al.

Summary: The infectivity of the omicron variant in hamsters was found to be lower than that of the ancestral D614G strain, with a significant decrease in viral RNA load in the lungs and no detectable infectious virus in this organ. Histopathological examination of the lungs from omicron-infected hamsters revealed no signs of peri-bronchial inflammation or bronchopneumonia.

ANTIVIRAL RESEARCH (2022)

Add to Collection

Editorial Material Infectious Diseases

Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529)-highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

Eskild Petersen et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Virology

Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa

Lulan Wang et al.

Summary: The discovery of the Omicron variant has sparked global concerns about its mutations, transmission, and immune escape properties. Current research suggests that the variant may impact viral infectivity and host immunity, and it may evolve from clade 20B.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Virology

Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective

Shailendra K. Saxena et al.

Summary: Omicron is the latest variant of concern of SARS-CoV-2, with more mutations compared to the previous Delta variant. Fifteen of these mutations are located in the receptor-binding domain of the spike glycoprotein, which may affect transmissibility, infectivity, antibody neutralization, and vaccine efficacy. The study provides insights into the mutational hotspots of Omicron and its global impact on transmission, testing, and immunity.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng et al.

Summary: The Omicron variant of SARS-CoV-2 has a higher affinity for ACE2 and can evade neutralizing antibodies more effectively compared to the Delta variant. A third dose of mRNA vaccine can provide enhanced protection. Omicron has lower replication in lung and gut cells and less efficiently cleaves its spike protein compared to Delta.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

Huiping Shuai et al.

Summary: The Omicron variant of SARS-CoV-2 shows reduced replication ability in human cells and attenuated pathogenicity in mice compared with the wild-type strain and other variants. It has lower efficiency in using TMPRSS2 and causes the lowest reduction in body weight and mortality rate among the tested strains.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki et al.

Summary: The Omicron variant of SARS-CoV-2 has spread rapidly in several countries and has shown lower fusogenicity and attenuated pathogenicity compared to the Delta variant.

NATURE (2022)

Add to Collection

Article Immunology

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

Hanjun Zhao et al.

Summary: The Omicron variant of SARS-CoV-2 has distinct virological characteristics compared to the Delta variant. It replicates more slowly and its entry pathway is mediated primarily through the endocytic pathway instead of TMPRSS2 pathway. This difference in entry pathway may have implications for the clinical manifestations or severity of the disease.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Letter Virology

On the Calculation of TCID50 for Quantitation of Virus Infectivity

Chengfeng Lei et al.

VIROLOGICA SINICA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Jin Wei et al.

Summary: Identification of essential host genes for SARS-CoV-2 infection, including ACE2 and Cathepsin L, and the discovery of pro-viral genes and pathways specific to SARS lineage and pan-coronavirus provide potential therapeutic targets and insights into pathogenesis of COVID-19. Small-molecule antagonists of these gene products inhibited SARS-CoV-2 infection across species, highlighting their conserved role in susceptibility to highly pathogenic CoVs.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release

Sebastien Eymieux et al.

Summary: Studies on SARS-CoV-2 have shown that early infection events involve clusters of single-membrane vesicles and annulate lamellae, with host cell-derived organelles transforming into virus factories later on.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Add to Collection

Article Infectious Diseases

Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile

Nathalie Wurtz et al.

Summary: The study tested 4 locally isolated strains of SARS-CoV-2 on 34 cell lines commonly used for isolating human pathogenic microorganisms, finding that 7 cell lines were able to support virus replication. Results indicate that there are differences in cytopathogenic effects and multiplication abilities in cells with different strains.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Bryan A. Johnson et al.

Summary: The genetic mutation in SARS-CoV-2 resulted in better fitness in some cells but lower replication capacity in human respiratory cell lines. Despite reducing disease symptoms, the Delta PRRA mutant provided protection against rechallenge with the wildtype SARS-CoV-2.

NATURE (2021)

Add to Collection

Review Anatomy & Morphology

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review

Subodh Kumar et al.

Summary: This study provides a detailed summary and evaluation of the most suitable cell lines for SARS-CoV-2 in vitro models, including cell culture-based studies and vaccine production, identifying the most widely used cell lines.

TISSUE & CELL (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

Michihito Sasaki et al.

Summary: This study identified SARS-CoV-2 variants with mutations at the cleavage motif of the S protein (S gene mutants) that undergo inefficient proteolytic cleavage, leading to smaller plaques and less infectivity. These mutants emerged rapidly through virus propagation in Vero cells and may have been unknowingly used in experiments, antiviral screenings, and vaccine development. The mutations affect the virus' entry pathway and cell tropism, emphasizing the importance of monitoring de novo S gene mutations during tissue-culture propagation.

PLOS PATHOGENS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.

CELL (2021)

Add to Collection

Article Biochemical Research Methods

CACO-2 cells: A continuous cell line with sensitive and broad-spectrum utility for respiratory virus culture

Rama Ramani et al.

Summary: The study compared the use of CACO-2, MDCK, and RhMK cells for isolating viruses from patients with influenza-like illness. The results showed that CACO-2 cells had a significantly higher respiratory virus isolation rate compared to RhMK and MDCK cells.

JOURNAL OF VIROLOGICAL METHODS (2021)

Add to Collection

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Add to Collection

Review Medicine, General & Internal

Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review

Mari Somerville et al.

Summary: The research found that an accelerated vaccine rollout is necessary to mitigate the spread of VOC. The increased severity of VOC requires proactive public health measures to control their spread. There is an urgent need for further research on the Delta variant and other emerging VOC on the impact of public health measures.

BMJ OPEN (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Drake M. Mellott et al.

Summary: K777, an irreversible inactivator of cysteine proteases, has shown reduction in the infectivity of SARS-CoV-2 in various host cells. By inhibiting the activity of host cathepsin L, this drug prevents the processing of viral spike protein, thereby reducing viral infectivity.

ACS CHEMICAL BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann et al.

Summary: The emerging SARS-CoV-2 variants may exhibit resistance to existing neutralizing antibodies and treatments, which could have significant implications for pandemic containment efforts.

CELL (2021)

Add to Collection

Article Public, Environmental & Occupational Health

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern

Lixin Lin et al.

Summary: Studies have shown that Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 have increased severity in terms of hospitalization, ICU admission, and mortality compared to the wild-type virus, with Beta and Delta variants posing higher risks.

FRONTIERS IN PUBLIC HEALTH (2021)

Add to Collection

Article Infectious Diseases

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

Dan Frampton et al.

Summary: This study describes the emergence of the B.1.1.7 variant of concern, its virological characteristics, and clinical severity in patients. Increased viral load was found in B.1.1.7 infection, but no association with severe disease was identified in the hospitalized cohort.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Biology

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization

Li Zhang et al.

Summary: Most SARS-CoV-2 variants exhibit slightly increased infectivity in human and monkey cell lines, with certain variants showing enhanced infectivity in specific cell types. Variants carrying specific amino acid mutations demonstrate increased abilities to infect certain cell types. Some variants show resistance to neutralization by antibodies and vaccines, primarily due to the E484K mutation.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz et al.

Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.

NATURE (2021)

Add to Collection

Article Infectious Diseases

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021

Inge Kroidl et al.

Summary: In February 2021, a breakthrough infection of the SARS-CoV-2 B.1.351 variant occurred in a fully Comirnaty vaccinated healthcare worker, which was then transmitted to their unvaccinated spouse. Sequencing revealed an identical virus in both spouses, with all nine single nucleotide polymorphisms typical for B.1.351. To date, no transmission of any variant of SARS-CoV-2 from a fully vaccinated person has been documented.

EUROSURVEILLANCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies

Claudia Pommerenke et al.

Summary: This study aims to identify suitable cancer cell lines for drug screening and virus research by screening ACE2 and TMPRSS2 genes in cancer cell lines; however, limited correlation between receptor expression and cell permissiveness was found in experimental results; in terms of viral infection, cell permissiveness is not only influenced by the presence of entry receptors but also by factors such as cellular resources, intrinsic immunity, and apoptosis.

PLOS ONE (2021)

Add to Collection

Article Virology

Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene

Alyssa T. Pyke et al.

Summary: The emergence of SARS-CoV-2 variants poses challenges to public health disease management, and the replication and evolutionary dynamics of the virus have important implications for the development of vaccines, antiviral therapies, and epidemiological control strategies for COVID-19.

VIRUSES-BASEL (2021)

Add to Collection

Article Microbiology

Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium

Franck Touret et al.

Summary: The new variant of the novel coronavirus, 20I/501Y.V1, has demonstrated a higher replication efficiency in human cellular models, potentially explaining its rapid spread in human populations.

MBIO (2021)

Add to Collection

Article Multidisciplinary Sciences

A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome

Doyeon Kim et al.

Summary: In this study, Kim et al. utilized various sequencing techniques to uncover the high-resolution translatome and transcriptome of SARS-CoV-2, identifying a novel translation initiation site TIS-L in the leader sequence. They found that TIS-L serves as a translation enhancer for ORF S and as translation suppressors for other ORFs, providing unique insights into the regulation of the SARS-CoV-2 translatome.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Medicine, General & Internal

SARS-CoV-2 Variants of Concern

Jun Yong Choi et al.

Summary: Since the beginning of the COVID-19 pandemic, the SARS-CoV-2 virus has evolved into various variants, with some designated as VOCs that have higher transmissibility and disease severity, potentially impacting vaccine effectiveness.

YONSEI MEDICAL JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlcochova et al.

Summary: The B.1.617.2 (Delta) variant of SARS-CoV-2 has lower sensitivity to antibodies and higher replication efficiency compared to other lineages, which may contribute to its dominance and reduced vaccine effectiveness, highlighting the need for continued infection control measures post-vaccination.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Shutoku Matsuyama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Denisa Bojkova et al.

NATURE (2020)

Add to Collection

Review Cell Biology

A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping

Maria Romano et al.

CELLS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Natacha S. Ogando et al.

JOURNAL OF GENERAL VIROLOGY (2020)

Add to Collection

Article Virology

Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

Zhe Liu et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Markus Hoffmann et al.

NATURE (2020)

Add to Collection

Article Cell Biology

Cell and animal models of SARS-CoV-2 pathogenesis and immunity

Sarah R. Leist et al.

DISEASE MODELS & MECHANISMS (2020)

Add to Collection

Article Genetics & Heredity

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

Andrew D. Davidson et al.

GENOME MEDICINE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients

William B. Klimstra et al.

JOURNAL OF GENERAL VIROLOGY (2020)

Add to Collection

Article Virology

Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP)

Lena Mautner et al.

VIROLOGY JOURNAL (2020)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Jennifer Harcourt et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Article Infectious Diseases

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study

Hin Chu et al.

LANCET MICROBE (2020)

Add to Collection

Article Immunology

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

Siu-Ying Lau et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS coronavirus infection

Claudia Diemer et al.

JOURNAL OF MOLECULAR BIOLOGY (2008)

Add to Collection

Article Biotechnology & Applied Microbiology

Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus

Xiaofeng Ren et al.

JOURNAL OF GENERAL VIROLOGY (2006)

Add to Collection

Article Virology

Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication

EC Mossel et al.

JOURNAL OF VIROLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.